Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors

MLA

Parneet K. Cheema, et al. “Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors.” Current Oncology, vol. 31, no. 10, Oct. 2024, pp. 6356–83. EBSCOhost, https://doi.org/10.3390/curroncol31100473.

APA

Parneet K. Cheema, Marco A. J. Iafolla, Husam Abdel-Qadir, Andrew B. Bellini, Nazira Chatur, Natasha Chandok, Vikram R. Comondore, Morven Cunningham, Ilana Halperin, Anne B. Hu, Diana Jaskolka, Saeed Darvish-Kazem, Masud H. Khandaker, Abhijat Kitchlu, Jasdip S. Sachdeva, Shane Shapera, Nicholas R. J. Woolnough, & Massey Nematollahi. (2024). Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors. Current Oncology, 31(10), 6356–6383. https://doi.org/10.3390/curroncol31100473

Chicago

Parneet K. Cheema, Marco A. J. Iafolla, Husam Abdel-Qadir, Andrew B. Bellini, Nazira Chatur, Natasha Chandok, Vikram R. Comondore, et al. 2024. “Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors.” Current Oncology 31 (10): 6356–83. doi:10.3390/curroncol31100473.